Researchers today announced AdaptiveFlow, an AI-informed platform that can virtually screen billions of drug-like molecules with a 1,000-fold reduction in computational costs over existing methods. Developed and validated by scientists from St. Jude Children's Research Hospital, University of P...
Source: [Phys.org](https://phys.org/news/2026-09-ai-adaptiveflow-redefines-large-scale.html)